Focus Stocks
Boston Scientific Upside Looming?
Published on Monday, 09 August 2010 01:45 Written by Christopher Lynn
New York, August 9th (TradersHuddle.com) - Shares of Boston Scientific Corporation (NYSE:BSX) ended the trading
session higher by $0.11 or 1.93% from its previous close. Boston Scientific's price action formed what is considered to be a
bullish engulfing candle that could very well signal continuation of trend or reversal on ongoing weakness.
Boston Scientific Corporation (NYSE:BSX) develops, manufactures, and markets minimally invasive medical device, which are used in interventional cardiology, cardiac rhythm management, and peripheral interventions, mong others.
Boston Scientific's recent stock range has been formed by a trough where calculated support was defined at $5.50 and by a peak that established the resistance level at $5.88, which could be used by traders planning their trades.
Traders wanting to establish a position in Boston Scientific or traders that are already holding the stock can use the bullish engulfing pattern to their advantage. The pattern provides a defined risk as it shows where the bears were able to push the stock down, before the bulls stepped in.
The bullish engulfing pattern is a leading indicator that provides an alert to the bulls that the trend will continue or that there is an immediate reversal to the short term weakness seen on the stock. Below an Engulfing Bullish Candle Illustration:

Related Articles
- Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries
- Boston Scientific to Participate in Leerink Swann 2012 Global Healthcare Conference
- Boston Scientific WallFlex® Enteral Stents Shown To Be Safe and Effective in Three Clinical Registries
- Boston Scientific Announces Global Launch of Expect™ 19 Flex Endoscopic Ultrasound Aspiration Needle
- Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2011
- Earnings Preview: Boston Scientific
- Boston Scientific Announces First Implant and Market Launch of PROMUS Element™ Plus Stent System in Europe
- Boston Scientific Announces Favorable Ruling in Patent Infringement Case
- Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2011 Financial Results
- Research Analyst's Up/Downgrades ( ZMH, SYK, STJ, BSX, GRMN, ONNN, AAP, RSH, KBH, LEN )
Related Partner Headlines
- Boston Scientific WallFlex Enteral Stents Shown To Be Safe and Effective in Three Clinical Registries - Benzinga
- Boston Scientific Stock Hits New 52-Week Low (BSX) - TheStreet.com
- Boston Scientific Inc. (BSX): Today's Featured Health Care Winner - TheStreet.com
- Boston Scientific Stock Hits New 52-Week Low (BSX) - TheStreet.com
- Boston Scientific Inc. (BSX): Today's Featured Health Services Winner - TheStreet.com
- Boston Scientific Slumps on 25% Profit Drop - TheStreet.com
- Boston Scientific Stock Hits New 52-Week Low (BSX) - TheStreet.com
- Boston Scientific Inc. (BSX): Today's Featured Health Services Loser - TheStreet.com
- Boston Scientific Stock Hits New 52-Week Low (BSX) - TheStreet.com
- Boston Scientific Inc. (BSX): Today's Featured Health Services Loser - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
Benzinga's Microcap Movers for Wednesday February 8, 2012 - Benzinga -
Five More Stocks ETFs Need More Of - Benzinga -
ETFs to Watch February 9, 2012 - Benzinga -
'Fast Money' Recap: Cisco's Back - TheStreet.com -
Benzinga's M&A Chatter for Wednesday February 8, 2012 - Benzinga -
Market Preview: Fearing the Inevitable Pullback - TheStreet.com -
Mike Khouw's OpenTable Inc Trade - Benzinga -
Fast Money Picks For February 9th - Benzinga
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,883.95 Trade time:4:02PM EST Value change:▲5.75 (0.04%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,349.96 Trade time:4:31PM EST Value change:▲2.91 (0.22%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,915.86 Trade time:5:16PM EST Value change:▲11.78 (0.41%)In The Wires
-
Daimler Excels in Anniversary Year 2011: Group EBIT From Ongoing Business up by 24% to Record Level of Euro 9 Billion -
Protalix Announces New Clinical Data on Taliglucerase Alfa to be Presented at the WORLD Lysosomal Disease Network Symposium -
UMC Reports Sales for January 2012 -
SS&C Appoints Punit Satsangi as Managing Director of EMEA Business Development -
gategroup Seeks to Extend and Amend Credit Facilities -
Publicis Groupe: 2011 Annual Results -
VIDEO from Siemens and Synaptic Digital: US Transportation Secretary LaHood to Visit Siemens Light Rail Manufacturing Plant in Sacramento -
Comstock Mining Announces Pricing of Public Offering of Common Stock










